Cargando…
Peripheral proteomic changes after electroconvulsive seizures in a rodent model of non-response to chronic fluoxetine
Major depressive disorder (MDD) is the psychiatric disorder with the highest prevalence in the world. Pharmacological antidepressant treatment (AD), such as selective serotonin reuptake inhibitors [SSRI, i.e., fluoxetine (Flx)] is the first line of treatment for MDD. Despite its efficacy, lack of AD...
Autores principales: | Lebeau, Rodolphe H., Mendez-David, Indira, Kucynski-Noyau, Laura, Henry, Céline, Attali, David, Plaze, Marion, Colle, Romain, Corruble, Emmanuelle, Gardier, Alain M., Gaillard, Raphaël, Guilloux, Jean-Philippe, David, Denis J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9659725/ https://www.ncbi.nlm.nih.gov/pubmed/36386166 http://dx.doi.org/10.3389/fphar.2022.993449 |
Ejemplares similares
-
Differential Peripheral Proteomic Biosignature of Fluoxetine Response in a Mouse Model of Anxiety/Depression
por: Mendez-David, Indira, et al.
Publicado: (2017) -
Pharmacological Mechanism of Ketamine in Suicidal Behavior Based on Animal Models of Aggressiveness and Impulsivity: A Narrative Review
por: Nguyen, Thi Mai Loan, et al.
Publicado: (2023) -
Psychiatric disorders and long COVID
por: Gasnier, Matthieu, et al.
Publicado: (2022) -
Ketamine and esketamine in suicidal thoughts and behaviors: a
systematic review
por: Jollant, Fabrice, et al.
Publicado: (2023) -
A method for biomarker measurements in peripheral blood mononuclear cells isolated from anxious and depressed mice: β-arrestin 1 protein levels in depression and treatment
por: Mendez-David, Indira, et al.
Publicado: (2013)